# Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy

> **NCT02694562** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 18 (actual)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **DEVICE:** 40um Embozene TANDEM Microspheres

## Key facts

- **NCT ID:** NCT02694562
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02694562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02694562, "Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02694562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*